External Search and Landscape Assessment
- Monitor the global oncology R&D landscape to identify emerging therapies, technologies, clinical programmes, and potential external partners. Develop and maintain a strong understanding of the China biotech ecosystem, including relevant companies, hospitals and academic institutions.
- Identify and prioritise external opportunities aligned with oncology portfolio priorities, including combination therapies, clinical trial collaborations and translational research.
- Build and maintain relationships with external biotech executives, investigators and other relevant stakeholders.
Scientific, Clinical, and Strategic Evaluation
- Evaluate the scientific rationale, pre-clinical and clinical evidence, biomarker strategy, trial design, feasibility, and potential patient impact of external opportunities. Assess the strategic fit, competitive landscape, differentiation potential, and relevance to oncology portfolio priorities.
- Coordinate cross-functional assessment of scientific, clinical, regulatory, operational, intellectual property, financial, and compliance considerations.
- Identify key risks, evidence gaps, and diligence requirements, and recommend appropriate next steps.
- Prepare clear evaluation summaries, recommendations, and decision materials for internal governance and senior stakeholders.
Collaboration Development and Management
- Lead external engagement with biotechnology companies and other potential collaborators from initial concept and evaluation through agreement, implementation, and milestone tracking.
- Coordinate global and regional stakeholders to ensure alignment on collaboration objectives, responsibilities, timelines, resources and governance. Facilitate effective communication and decision-making across internal functions and external partners.
- Ensure that collaboration activities comply with applicable regulations, company policies, confidentiality requirements, data protection obligations, and ethical standards.
REQUIREMENTS
Academic / Professional Qualification
- An advanced degree in a relevant discipline, such as an MD, PhD, PharmD, or equivalent degree in life sciences, medicine, pharmacy, public health, or a related field.
- A minimum of three years’ relevant experience in the pharmaceutical, biotechnology, or broader life sciences industry is required. Experience in R&D, Medical Affairs, strategy, business development, external partnering, venture investing, investment banking, or management consulting, preferably in oncology, is highly valued.
- Prior experience engaging with external partners and managing complex, cross-functional projects is preferred.
Technical / Skill
- Strong understanding of the oncology R&D landscape, clinical development, and preclinical research.
- Ability to evaluate scientific proposals and translate findings into clear recommendations.
- Strong project management, communication, stakeholder-management, data-interpretation, and presentation skills.
- Fluency in English and Mandarin Chinese, with strong written and verbal communication skills in both languages.
Desirable Attribute
- Ability to collaborate effectively across internal functions and with external partners.
- Strategic thinking, sound judgement, adaptability, and the ability to work effectively in a complex and changing environment.
- A high level of integrity and professionalism, with a strong commitment to science and innovation.
Date Posted
18-8月-2026
Closing Date
31-10月-2026
AstraZeneca embraces diversity and equality of opportunity. We are committed to building an inclusive and diverse team representing all backgrounds, with as wide a range of perspectives as possible, and harnessing industry-leading skills. We believe that the more inclusive we are, the better our work will be. We welcome and consider applications to join our team from all qualified candidates, regardless of their characteristics. We comply with all applicable laws and regulations on non-discrimination in employment (and recruitment), as well as work authorization and employment eligibility verification requirements.